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The matrix protein M1 of the Influenza A virus (IAV) is supposed to mediate viral assembly
and budding at the plasma membrane (PM) of infected cells. In order for a new viral par-
ticle to form, the PM lipid bilayer has to bend into a vesicle toward the extracellular side.
Studies in cellular models have proposed that different viral proteins might be responsi-
ble for inducing membrane curvature in this context (including M1), but a clear consen-
sus has not been reached. In the present study, we use a combination of fluorescence
microscopy, cryogenic transmission electron microscopy (cryo-TEM), cryo-electron tomog-
raphy (cryo-ET) and scanning fluorescence correlation spectroscopy (sFCS) to investigate
M1-induced membrane deformation in biophysical models of the PM. Our results indicate
that M1 is indeed able to cause membrane curvature in lipid bilayers containing negatively
charged lipids, in the absence of other viral components. Furthermore, we prove that pro-
tein binding is not sufficient to induce membrane restructuring. Rather, it appears that sta-
ble M1–M1 interactions and multimer formation are required in order to alter the bilayer
three-dimensional structure, through the formation of a protein scaffold. Finally, our results
suggest that, in a physiological context, M1-induced membrane deformation might be mod-
ulated by the initial bilayer curvature and the lateral organization of membrane components
(i.e. the presence of lipid domains).
Introduction
The Influenza A virus (IAV) buds from the plasma membrane (PM) of infected cells and, while doing
so, acquires a lipid envelope from its host [1–4]. During this step, the PM lipid bilayer is initially bent
into a vesicle, toward the extracellular side [5]. Assembly of viral components, bending of the lipid bilayer
and the resulting budding of virions are essential parts of the IAV replication cycle and, therefore, their
regulation could be a potential target for antiviral therapies.
IAV assembly is thought to be orchestrated by its matrix protein M1, which mediates the interactions
among other viral components and the lipids in the PM [6]. In spite of its fundamental importance, this
process is still not fully understood. We and others have investigated M1–M1 and M1–lipid interactions,
both in model membranes and cellular systems [7–9]. It was shown that M1 interacts electrostatically via
its N-terminal domain with acidic lipids and this interaction modulates protein multimerization [7,9,10].
On the other hand, the process by which M1 or other viral proteins can induce membrane curvature
during IAV budding is less clear. This issue has been investigated in cellulo without reaching a clear con-
sensus [11]. In some cases, it was demonstrated that M1 alone is sufficient to induce budding at the PM,
without the need for other viral components [12,13]. Other studies have shown instead that IAV hemag-
glutinin and neuraminidase are needed to produce viral particles, while M1 might not play a significant
role [14–16]. Another group suggested that, in the presence of significant M1–PM binding, the protein
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might be capable of inducing budding [17]. In light of these observations, it would be therefore very interesting to
investigate M1–lipid interactions in a controlled environment and clarify whether the protein has indeed the ability
to induce curvature in lipid bilayers on its own. In this context, giant unilamellar vesicles (GUVs) provide a simplified
model for the PM, consisting of a non-supported lipid bilayer with well-defined composition and physical properties
[18–21]. GUVs have been used in the past to investigate the interplay between viral proteins and lipid membranes
and, specifically, protein-induced alterations in the three-dimensional structure of the bilayer [22–25]. In this work,
we used a similar approach to investigate the interaction between IAVM1 and lipid membranes, using a combination
of fluorescence microscopy imaging, scanning fluorescence correlation spectroscopy (sFCS) [26], cryogenic trans-
mission electron microscopy (cryo-TEM), as well as cryo-electron tomography (cryo-ET). Our results indicate that
M1 is capable of causing membrane deformation, also in the absence of other proteins. Furthermore, we quantita-




All lipids (i.e. dioleoyl-sn-glycero-3-phosphocholine (DOPC), 2-distearoyl-sn-glycero-3-phosphocholine (DSPC),
1,2-dioleoyl-sn-glycero-3-phospho-l-serine (DOPS), phosphatidylinositol 4,5-bisphosphate (PIP2), 1,2-dipalmitoy
l-sn-glycero-3-phospho-(1′-rac-glycerol) (DPPG), cholesterol and 1,2-dioleoyl-sn-glycero-3-phosphoethanolami
ne-N-Lissamine rhodamine B sulfonyl (Rhodamine-DOPE)) were obtained from Avanti Polar Lipids (Alabaster, Al-
abama, U.S.A.). Alexa Fluor 488 succinimidyl ester was obtained from Life Technologies (Darmstadt, Germany).
2-(4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy) propoxy) phenoxy acetic acid (PHE) was purchased from Cayman
Chemical (Ann Arbor, MI, U.S.A.). Ten-fold concentrated phosphate buffer (PBS, 100 mM phosphate buffer, 27 mM
potassium chloride and 1.37 M sodium chloride at pH 7.4) was from Alfa Aesar (Haverhill, MA, U.S.A.). Glucose
was from VWR Chemicals (Radnor, PE, U.S.A.). All other chemicals were purchased from ROTH (Karlsruhe, Ger-
many), unless differently specified. Indium tin oxide (ITO)-coated coverslips, 20× 20 mm, thickness #1, 8–12 Ohms
resistivity, were purchased from SPI supplies (West Chester, PA, U.S.A.).
Preparation of GUVs
GUVs were prepared using the electroformation method [27,28]. Different lipid compositions were used to prepare
the vesicles, as specified in each case in the ‘Results’ section. Typically, DOPC and cholesterol weremixedwith various
amounts of negatively charged lipids (e.g. DOPS) at molar ratios between 10 and 50 mol%. Rhodamine-DOPE 0.05
or 0.1 mol% was added as a tracer to allow GUV membrane visualization by confocal microscopy. The GUV elec-
troformation chamber consisted of two conductive ITO coverslips facing each other and separated by a 3-mm thick
Teflon spacer. The total volume of the chamber was∼300 μl. Thirty microliters of 3 mM lipid solution in chloroform
and/or ethanol were spread on a preheated ITO coverslip, forming a thin lipid film. The solvent was evaporated using
a nitrogen flow for 5 min at room temperature (note that solvent evaporation under vacuum for 1 h did not show a
difference in vesicle behavior). After assembly, the chamber was filled with a sucrose solution in deionized water (e.g.
150 mM) and connected to a voltage generator (AC generator FG 250 D, H-Tronic, Hirschau, Germany). For exper-
iments at low pH, the chamber was filled with 150 mM sucrose, 10 mM acetate buffer solution at pH 5. A sinusoidal
electric field of 1.4 V at 10 Hz was applied for 1.5 h at room temperature. To facilitate the detachment of GUV from
the slides, the voltage was decreased to 0.5 V for 30 min.
Preparation of GUVs showing phase separation
Vesicles were prepared as described in the previous paragraph, using a lipidmixture consisting of 10mol% cholesterol,
45 mol% DOPC, 15 mol% DPPG and 30 mol% DSPC. Additionally, 0.05 mol% Rhodamine-DOPE was added to
visualize the different lipid domains. Lipids were dissolved in chloroform/methanol 9:1 v:v (5 mM, prepared freshly
and kept under a nitrogen atmosphere). The obtained lipid film was subjected to the electroformation procedure
(see previous paragraph) at 50◦C for 1.5 h. The chamber was then cooled down slowly at room temperature before
imaging.
Expression and puriﬁcation of recombinant matrix protein (M1)
constructs
6xHis-tag M1 protein from Influenza A/FPV/Rostock/34 was expressed and purified, using a protocol adapted from
Hilsch et al. [9]. Rosetta Escherichia coli (DE3) pLysS-competent cells were grown in 1 l medium (containing 0.2%
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glucose, 50 mg/ml chloramphenicol and 50 mg/ml ampicillin) until reaching OD600∼0.7 at 37◦C. Then, protein ex-
pression was induced by addition of IPTG (0.4 mM) while shaking for 3 h at 37◦C. Bacteria were harvested by cen-
trifugation for 10 min at 4800 rpm (Thermo Lynx 4000 F12-6 rotor, Thermo Fisher Scientific, Waltham, MA, United
States). The obtained pellets were stored at −80◦C until needed. On a different day, pellets were resuspended in lysis
buffer (16 mM Na2HPO4, 146 mM KH2PO4, 500 mM NaCl, 5.4 mM KCl, EDTA-free protease inhibitor cocktail, 1
mMPMSF, 200μg/mlDNAse), quickly frozen (15min at−80◦C) and incubated on a rotation shaker at 4◦C for 30–60
min. All the following steps were performed at 4◦C. The bacteria were completely lysed using a French press (Glen
Mills, NJ, U.S.A.) run at 1000 psi. Finally the obtained bacterial lysate was clarified by centrifugation at 21000 rpm for
30 min (Thermo Lynx 4000, A27-8 rotor, Thermo Fisher Scientific, Waltham, MA, United States). The supernatant
was incubated with 2 ml TALON resin (Takara, Saint-Germain-en-Laye, France) in a tube using a rotation shaker for
30–60 min. The resin was then washed with an equilibration buffer (8 mM Na2HPO4, 1.5 mM KH2PO4, 500 mM
NaCl, 2.7 mMKCl, pH 7.4) and incubated on shaker for 15 min. The resin was washed again two to three times with
an intermediate washing buffer consisting of the equilibration buffer with additional 60 mM imidazole, pH 7.2. Fi-
nally, M1 was eluted with an elution buffer (two-fold concentrated PBS with additional 180 mM imidazole, pH 7.4).
Typical (maximal) protein concentrations were ∼60 μM. SDS/PAGE was performed to verify protein purity. Pro-
tein concentration was determined using UV absorbance at 280 nm on an Agilent 8453 UV/Vis spectrophotometer
(Agilent Technologies, Milford, MA, U.S.A.).
For the experiments performed at pH 5, the protein was purified directly at low pH. In particular, the intermediate
washing buffer contained 20 mM imidazole (pH 6.5). The elution buffer contained 50 mM sodium acetate and 300
mM NaCl (pH 5).
M1-derived constructs (i.e. N-terminal domain 1–164 aa (NM1) and C-terminal domain 165–252 aa (CM1)) were
purified at pH 7.4 as previously described [10]. The elution buffer used for NM1 was the same as the one used for
M1. The elution buffer used for CM1 was PBS with additional 150 mM imidazole (pH 7.4).
Protein labeling for ﬂuorescence microscopy
The purified protein was conjugated, if needed, with the primary amine-reactive dye Alexa Fluor 488 succinimidyl
ester. Freshly purified protein (in elution buffer) was incubated with the reactive dye (10:1 molar ratio) for 2 h at 4◦C,
at the desired pH (7.4 or 5).
For simple imaging experiments, the protein–dye mixture was directly used, without further separation, as
described in the next paragraph. For quantitative experiments (e.g. sFCS experiments), the labeled protein
(M1-Alexa488) was separated from the free dye using size-exclusion chromatography (PD-10, GE Healthcare, Mu-
nich, Germany). The labeled protein was eluted with diluted PBS (pH 7.4), matched to the desired final osmolarity, as
described in the next paragraph. Protein concentration and labeling efficiency were determined by absorbance at 280
and 490 nm, respectively. The maximum protein concentrations were typically ∼40 μM, while labeling efficiencies
ranged between 0.1 and 0.15 dye/protein.
Protein–GUV samples and imaging
BeforemixingwithGUVs, the protein solution (i.e.M1 in elution buffer) was dilutedwith deionizedwater to reach the
target approximate osmolarity. For example, for experiments in which GUVs were prepared in 150 mM sucrose (see
experiments shown in Figures 1, 3 and 4), the purified M1 solution (with or without Alexa Fluor 488 succinimidyl
ester) was diluted approximately five-fold. Typical protein concentrations at this step were ∼12 μM. The protein
solution was then mixed with the GUV suspension with different volume ratios, in order to obtain the final desired
protein concentration (usually between 5 and 10 μM) in a total of 300 μl volume, and transferred to 35- mm dishes
(CellVis, Mountain View, CA) with optical glass bottoms, previously passivated with a 1% bovine serum albumin
solution. This procedure ensured that sugar concentration and osmotic pressure across GUVmembranes were always
reproducible, at the expense of slight variations in buffer composition (e.g. NaCl between ∼25 and ∼70 mM, as
indicated in each figure caption). It is worth mentioning that no significant alteration in M1–lipid interactions was
reported in the presence of NaCl between 0 and 150 mM [7].
For the experiments carried in the presence of the M1-multimerization inhibitor PHE, M1 (∼60 μM) was incu-
bated with PHE (100μM, unless differently stated) for 30min directly in the elution buffer. Subsequently, themixture
was incubated with 4 μMAlexa Fluor 488 succinimidyl ester, for 2 h at 4◦C. Finally, the protein solution was diluted
with deionized water to approximatively match the osmolarity of the vesicle suspension and mixed with the GUVs,
so to obtain a final protein concentration of 10 μM (and ∼25 μM PHE).
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Imaging experiments at pH 5 were carried out as follows: M1 was purified and labeled as described in ‘Expression
and purification of recombinant matrix protein (M1) constructs’ and ‘Protein labeling for fluorescence microscopy’
sections directly at pH 5. The protein-dye solution in elution buffer (50 mM sodium acetate and 300 mM NaCl, pH
5) was subsequently diluted approximately three-fold using deionized water, to a final protein concentration of ∼13
μM (in ∼16 mM sodium acetate, ∼90 mM NaCl). This solution was finally mixed with the GUV suspension, so as
to obtain a final protein concentration of 10 μM.
We have verified that the presence of imidazole does not affect membrane curvature for at least 2 h and that Alexa
Fluor 488 succinimidyl ester does not significantly interact with GUVs (data not shown). Nevertheless, in the case of
samples that required higher protein concentrations (i.e. >10 μM M1) or extensive removal of free dye, the elution
buffer was exchanged after protein labeling, using a PD-10 column. For example, for the sFCS experiments described
in ‘M1 exhibits reduced dynamics and high degree of multimerization in deformed vesicles’ section, the protein was
eluted using two-fold diluted PBS (pH 7.4), to approximatiely match the osmolarity of GUV samples prepared in 150
mM sucrose.
Confocal fluorescence laser scanning microscopy (LSM) imaging was performed on a Zeiss LSM780 system (Carl
Zeiss, Oberkochen, Germany) using a 40× 1.2 NA water-immersion objective. Samples were excited with a 488-nm
argon laser (for the fluorophores Alexa Fluor 488 succinimidyl ester) or a 561-nm diode laser (for the fluorophore
Rhodamine-DOPE). For measurements performed using 488 nm excitation, fluorescence was detected between 499
and 695 nm, after passing through a 488-nm dichroic mirror, using GaAsP detectors. For measurements performed
with 561 nm excitation, fluorescence emission was separated using a 488/561 nm dichroic mirror and was detected
between 570 and 695 nm.
ImageJ (NIH, Bethesda, MA, U.S.A.) was used to analyze microscopy images and determine the circularity of
randomly selected GUVs. Vesicles with a circularity<0.85 were defined as deformed/non-spherical.
Liposome preparation for cryo-TEM
Large unilamellar vesicles (LUVs) were prepared by extrusion. The desired lipids mixture (DOPC + 40 mol% DOPS)
was dissolved in chloroform and then evaporated under nitrogen stream at room temperature to form a lipid film.
Films were then rehydrated in PBS (pH 7.4). The obtained dispersion (2 mM total lipid concentration) was vigor-
ously vortexed for 2–5min. The diameter of the obtainedmultilamellar vesicles was reduced by serially extruding the
suspension 11-times through a 100-nm pore diameter polycarbonate membrane (Whatman, Maidstone, U.K.) with a
hand-held extruder (Avanti Polar Lipids, AL,U.S.A.). Liposome size (∼130 nmdiameter in average) wasmeasured via
dynamics light scattering, using a Zetasizer HS 1000, (Malvern,Worcestershire, U.K.). The purifiedM1 (unlabeled) in
elution buffer was diluted with deionized water to approximatively match the osmolarity of the liposome suspension
(∼2.6-fold dilution). LUVs and protein solution were mixed in a total volume of 800 μl so to obtain a 10-μM final
M1 concentration. Typical final lipid concentrations were∼0.5 to 1 mM. Perforated carbon film-covered microscop-
ical 200 mesh grids (R1/4 batch of Quantifoil, MicroTools GmbH, Jena, Germany) were cleaned with chloroform
and hydrophilized by 60 s glow discharging at 8 W in a BAL-TEC MED 020 device (Leica Microsystems, Wetzlar,
Germany), before 5 μl aliquots of the liposome/protein solution were applied to the grids. The samples were vitrified
by automatic blotting and plunge freezing with a FEI Vitrobot Mark IV (Thermo Fisher Scientific, Waltham, U.S.A.)
using liquid ethane as cryogen.
Cryo-TEM
The vitrified specimens were transferred under liquid nitrogen into the autoloader of a FEI TALOS ARCTICA elec-
tron microscope (Thermo Fisher Scientific, Waltham, U.S.A.). This microscope is equipped with a high-brightness
field-emission gun (XFEG) operated at an acceleration voltage of 200 kV.Micrographs were acquired on a FEI Falcon
3 4k× 4k direct electron detector (Thermo Fisher Scientific, Waltham, U.S.A.) using a 70-μm objective aperture at a
primary magnification of 28 or 45 k, corresponding to a calibrated pixel size of 3.69 or 2.29 A˚/pixel, respectively.
Cryo-ET
Single-axis tilt series (+−60◦ in 2◦ tilt angle increments) was recorded with the Falcon 3 direct electron detector at
full resolution (28 K primary magnification) with a total dose lower than 70 e−/A˚2. Tomogram reconstruction was
performed using Thermo Fisher Inspect3D software. Amira, Version 6.0 (FEI, Oregon, U.S.A.) was used for visual-
ization.
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sFCS
sFCS measurements were performed on a Zeiss LSM780 system using a 40× 1.2 NA water- immersion objective.
M1-Alexa488 was excited with a 488-nm argon laser. Fluorescence was detected after passing through a 520/35 nm
bandpass filter. Data acquisition and analysis were performed as described by Dunsing et al. [26,29]. Briefly, line
scans of 128 × 1 pixels (pixel size 160 nm) were performed perpendicular to the GUV membrane with a 472.73
μs scan time. Typically, 600000 lines were acquired (total scan time ∼4 min) in photon counting mode. Low laser
power was used (∼1 μW) to avoid photobleaching and fluorescence saturation effect. Data were exported as TIF
files, and then imported and analyzed in Matlab (MathWorks, Natick, MA) using custom-written code [26,29]. The
analysis thus obtained auto-correlation curves with a two-dimensional diffusionmodel resulted in the determination
of the number of fluorophores in the confocal volume (N) and their apparent diffusion times. Furthermore, total
fluorescence intensity at the GUVmembrane and M1-Alexa488 brightness were determined. Protein brightness and
fluorescence intensity were normalized to account for day-to-day variations in laser power, optics alignment and
degree of protein labeling, as described in Hilsch et al. [9]. An approximate conversion from normalized brightness
into the size of protein multimers is discussed in ‘M1 exhibits reduced dynamics and high degree of multimerization
in deformed vesicles’ section, assuming for the sake of simplicity that the lowest measured average brightness value
(∼0.025 a.u., sample ‘pH 5’) corresponds to M1 dimers [30] and using the formula described in Dunsing et al. [31],
with pf = 0.1 and ε = 0.0227.
Statistical significance of differences among sFCS datasets were determined using a two- sided t test with distinct
variances (ttest2 routine, Matlab).
Results
M1 induces membrane deformation in GUVs containing negatively
charged lipids
In order to clarify whether M1 is sufficient to induce membrane deformation in protein-free lipid bilayers, we incu-
bated GUVs of different compositions in the presence of 5 μMM1-Alexa448. It is worth noting that approximately
one in ten proteins were labeled (see ‘Materials and Methods’ section). Freshly prepared lipid vesicles included in-
creasing amounts of DOPS (from 0 to 50 mol%), as it was shown that this lipid promotes M1 binding via electrostatic
interactions [7–10,32]. GUVs were stained with trace amounts of a fluorescent lipid (Rhodamine-DOPE) and ob-
served via confocal LSM. According to Figure 1A–D,G, significant membrane deformation was observed for GUVs
containing high amounts of DOPS (i.e. ≥30 mol%). GUVs containing low amounts of DOPS (e.g. 10 mol%, Figure
1B) or in control sampleswithout protein (Supplementary Figure S1A) remainedmostly spherical.We did not observe
significant changes in the shape of deformed GUVs during the measurement time.
Although alterations in membrane shape could be obtained also by using non-fluorescent M1 (Supplementary
Figure S1B), labeling of M1 was instrumental to directly visualize protein binding and organization. Figure 1E,F and
the inset in panel (D) show the spatial distribution of M1-Alexa488 typically observed in the samples represented in
panels (A,B,D), respectively. As expected, in the absence of DOPS, very little binding of M1 to the membrane was
observed andmost of the protein could be found in solution outside the GUVs (Figure 1E). In the case of GUVs con-
taining 10mol%DOPS,M1 bound homogeneously to the lipid membrane (Figure 1F). M1 binding appears therefore
necessary but, in general, not sufficient to induce membrane deformation. Interestingly, we noticed that the protein
bound homogeneously to non-spherical GUVs as well (e.g. Figure 1D and inset). Also, the protein fluorescence inten-
sity inside and outside deformedGUVswas, in general, not distinguishable (see e.g. inset in Figure 1D). This indicates
that M1 might have crossed the membrane into the lumen of the vesicles in many cases. Nevertheless, we observed
that the shape of deformed GUVs was qualitatively reproducible also whenever M1 was more clearly excluded from
the lumen of the vesicles (see Supplementary Figure S1B,C).
Additionally, an increase in membrane acyl-chain order (by increasing cholesterol concentration to 40 mol%,
Figure 1H) did not appear to suppress membrane deformation. GUV shape alterations could also be observed if
DOPS was substituted by other negatively charged lipids, e.g. PIP2 or PG (data not shown). Finally, we observed
that the N-terminal domain of M1 (M1N aa. 1–164) is sufficient to induce membrane deformation. The C-terminal
domain (M1C aa. 165–252) shows no effect on GUV shape and, as previously reported [10], has a low degree of
membrane binding ( Supplementary Figure S2).
Table 1 (row ‘M1 pH 7.4’) shows a quantitative overview regarding the amounts of deformed GUVs observed for
different compositions, in conditions similar to those relative to the samples shown in Figure 1. In order to clearly
detect protein binding and, thus, include in the quantification only larger GUVs (>∼10 μmdiameter) that displayed
a significant amount of bound M1, we increased the protein concentration to 10 μM (18 μM for GUVs with only
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 1. Shape alterations induced by M1 in DOPS-containing GUVs
(A–D) Typical GUVs composed of 20 mol% Cholesterol, DOPC and increasing amounts of DOPS ((A) 0 mol%, (B) 10 mol%, (C) 30
mol%, (D) 50 mol%) observed via confocal LSM after 30-min incubation with 5 μM M1-Alexa488. Rhodamine-DOPE (0.01 mol%,
red channel) was added to allow the visualization of the lipid bilayer via confocal LSM. Inset in (D–F): Fluorescence signal originating
from M1-Alexa488 (green channel) for typical GUVs containing 0 mol% DOPS ((E) corresponding to the sample represented in (A)),
10 mol% DOPS ((F) corresponding to the sample represented in (B)) and 50 mol% DOPS (inset in (D)). (G) Three-dimensional
reconstruction of a typical GUV containing 30 mol% DOPS in the presence of 5 μM M1-Alexa488 (corresponding to the sample
represented in (C)). The fluorescence signal originates from Rhodamine-DOPE (0.01 mol%, red channel). (H) Confocal LSM image
of a typical GUV composed of 30 mol% DOPC, 30 mol% DOPS and 40 mol% cholesterol, in the presence of 5 μM M1-Alexa488.
The fluorescence signal originates from Rhodamine-DOPE (0.01 mol%, red channel). All GUVs contained 150 mM sucrose in their
lumen and were suspended in a phosphate buffered protein solution (NaCl ∼25 mM, pH 7.4) with similar osmolarity (see ‘Materials
and methods’ section). Scale bars are 5 μm. Images were acquired at 23◦C. Abbreviation: LSM, laser scanning microscopy.
Table 1 Quantitative characterization of the amounts of non-spherical GUVs for different membrane compositions
Relative amounts of deformed GUVs
GUV composition
DOPC + DOPS DOPS 10 mol% DOPS 20 mol% DOPS 30 mol% DOPS 40 mol% DOPS 50 mol%
M1 0% 24% 49% 83% 89%
pH 7.4 (n=29) (n=33) (n=81) (n=84) (n=26)
M1 + PHE 8% 13% 20%
pH 7.4 (n=26) (n=23) (n=15)
M1 0% 12% 17%
pH 5 (n=46) (n=25) (n=23)
Percentages of deformed GUVs are reported for different experimental conditions discussed in the text. The row ‘M1 pH 7.4’ refers to the conditions
described for the experiments shown in Figure 1. The row ‘M1 + PHE pH 7.4’ refers to the experiments described in the context of Figure 5A. The
observations reported in this table were performed by treating M1-Alexa488 with PHE concentrations between 75 and 150 μM. The row ‘M1 pH 5’ refers
to the experiments described in the context of Figure 5B. The total numbers of observed GUVs (n) refer in all cases to GUVs that were clearly labeled
with ﬂuorescent M1 and had a diameter > ∼10 μm. GUVs that did not display clearly recognizable M1-Alexa488 binding were not considered. The
concentration of M1-Alexa488 was 10 μM, with the exceptions of the DOPS 10 mol% (18 μM) and DOPS 50 mol% (6 μM) samples. The percentages
summarize the results of at least two independent experiments.
10 mol% DOPS). Visual inspection of several vesicles confirmed that membrane deformation is facilitated by higher
DOPS concentrations. A quantitative characterization of M1 binding to deformed membranes is described below
(‘M1 exhibits reduced dynamics and high degree of multimerization in deformed vesicles’ section).
M1-induced membrane bending in LUVs observed at high resolution
Characterization of bilayer deformation in GUVs via confocal LSM is limited by optical resolution. In order to ob-
tain high-resolution information regarding the interplay between M1 binding and membrane curvature, we used
6 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 2. M1 modiﬁes the curvature of LUV membranes
(A,B) Typical cryo-TEM images of liposomes composed of 40 mol% DOPS in the presence of 10 μM M1 (phosphate buffer pH
7.4, NaCl ∼120 mM, see ‘Materials and methods’ section). The arrows in panels (A,B) indicate protein-free membrane portions of
vesicles (green arrows) or M1-bound portions of the bilayer which appear thicker (red arrows: tubules, yellow arrows tubule necks
and inward vesiculation), due to the presence of bound M1. Scale bars are 100 nm. (C) Cryo-ET of a typical M1-bound liposome
(tomography series +−60◦ at 2◦ angular increment): the image shows a 15-nm thick section through the three-dimensional volume
just in the middle of an LUV incompletely bound to M1 (note the inverted contrast of the so-called voltex representation, i.e. lipid-
and protein densities appear light). The numbers indicate the thickness of the bare lipid bilayer (∼4 nm), lipid bilayer with bound
M1 (∼8–9 nm) and the diameter of a tubule originating from a vesicle (∼36 nm).
cryo-TEM to observe LUVs in the presence of M1. Lipid vesicles containing DOPC and 40 mol% DOPS were in-
cubated with 10 μM (unlabeled) M1 before freezing. The representative results shown in Figure 2A,B indicate that
M1 binds to a large fraction of the lipid bilayers. By observing the apparent bilayer thickness, it is possible to distin-
guish regions of the bilayer with bound M1 (red and yellow arrows) from those devoid of protein (green arrows). In
order to obtain a better insight into the conditions at the membrane, we have employed cryo-ET. Slices of the final
3D reconstruction, calculated from tilting series of images of the LUV embedded in vitreous ice, provide a more ac-
curate representation of membrane spatial features, compared with individual cryo-TEM projection images. Figure
2C shows such a 15-nm thick section through the three-dimensional volume just in the middle of a LUV partially
covered by theM1 protein. The protein-free bilayer has a thickness of approximately 4 nm. Regions in which a layer of
M1 appears to be bound to the lipid bilayer are between 8 and 9 nm thick. Interestingly, the presence ofM1 on vesicles
is clearly correlated to changes in vesicle shape. Protein-free LUV surface regions display a positive mean curvature
(referred to the membrane monolayer exposed to the protein solution) similar to that observed for control samples
(Supplementary Figure S3). Membrane regions to which M1 has bound display various spatial features. Most often,
we observed outward tubulation, i.e. membrane surfaces with zero Gaussian curvature, as indicated by the red arrows
in Figure 2. In other cases, we observed inward vesiculation or membrane regions with negative Gaussian curvature
(yellow arrows in Figure 2).
Lipid domains modulate M1-induced membrane bending
It was previously reported that IAV assembly and budding occurs in correspondence of confined PM domains [11].
Furthermore, it is known that M1 binds to negatively charged lipids [7,33]. To investigate whether the spatial con-
finement of acidic lipids withinmembrane domains canmodulateM1-inducedmembrane deformation, we produced
GUVs displaying phase separation in ordered domains (i.e. bilayer regions characterized by highly ordered lipid acyl
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 3. M1 binding to acidic lipid microdomains causes localized membrane deformation
(A) Typical GUV composed of cholesterol:DPPG:DSPC:DOPC, 10:15:30:45 molar ratios, imaged via confocal LSM. Phase sepa-
ration was observed by labeling the vesicles with Rhodamine-DOPE 0.01 mol% (red channel, strongly enriched in the disordered
phase) and introducing water-soluble Alexa Fluor 488 succinimidyl ester in the outer milieu of the vesicles (green channel). (B,C)
Typical GUVs with the same compositions as in (A), in the presence of 10 μM M1-Alexa488. The protein is visualized in the green
channel and the lateral distribution of Rhodamine-DOPE is represented in the red channel. GUVs similar to that shown in (B) were
observed in approximately 75% of the cases. GUVs similar to that shown in (C) (inward budding of the whole ordered domain)
were observed in approximately 25% of the cases. All GUVs contained 150 mM sucrose in their lumen and were suspended in a
phosphate buffered protein solution (NaCl ∼45 mM, pH 7.4) with similar osmolarity (see ‘Materials and methods’ section). Scale
bars are 5 μm. Images were acquired at 23◦C.
chains, enriched in saturated phosphatidylcholine and, reasonably, saturated phosphatidylglycerol) and disordered
domains (enriched in unsaturated phosphatidylcholine). We have produced similar (supported) lipid bilayers in the
past by using a mixture of DOPC, DSPS, DSPC and cholesterol [34]. When producing GUVs, we have noticed that
exchanging the saturated phosphatidylserine (i.e. DSPS) with saturated phosphatidylglycerol (i.e., dipalmitoylphos-
phatidylglycerol, DPPG) improved the yield of phase-separated GUVs. Figure 3A shows an example of such GUVs
observed via confocal microscopy (cholesterol:DPPG:DSPC:DOPC, 10:15:30:45molar ratios). The red channel refers
to the lateral distribution of a fluorescent unsaturated lipid analog (i.e. Rhodamine-DOPE), which strongly parti-
tions into the disordered bilayer phase (plausibly, rich in DOPC). The green channel refers to the distribution of a
water-soluble fluorescent dye (Alexa Fluor 488 succinimidyl ester). The presence of the dye in the outer milieu al-
lowed the visualization of the whole GUV shape. Ordered lipid domains (plausibly, rich in DPPG and DSPC) can be
thus simply identified by the low-partition of Rhodamine-DOPE and appear as dark membrane regions.
After addition of 10 μM M1-Alexa488, approximately half the vesicles showed deviations from spherical shape.
More in detail, we observed in certain cases M1-Alexa488 (green channel) bound to irregularly shaped ordered do-
mains (approximately 75% of the cases, typical domain size was approximately 20 +− 10 μm), as shown, e.g. in Figure
3B. In other instances, we observed M1-Alexa488 bound to smaller ordered domains which were budding inward
(approximately 25% of the cases, typical domain size approximately 4 +− 1 μm), as shown, for example in Figure 3C.
In agreement with previous observations [35,36], we noticed that ordered domains sometime protruded outward
(see e.g. Supplementary Figure S4A), independently of the presence of the protein. Finally, in the vast majority of
cases, M1-Alexa488 appeared to be excluded from the lumen of the vesicles (see e.g. Supplementary Figure S4B,C for
enhanced contrast versions of Figure 3B,C).
Membrane deformation is accompanied by the formation of a stable
M1–M1 network
So far, we have shown that M1–lipid interactions appear to cause alterations in the spatial organization of the bilayer.
We next investigated whether M1–M1 interactions are also involved in the membrane deformation process. Figure
4A,B shows a typical GUV containing 30 mol% DOPS in the presence of 5 μM M1-Alexa488. As expected, within
30 min of incubation, deformed vesicles could be observed by monitoring the spatial distribution of a fluorescent
lipid analog (Figure 4B) or the labeled protein itself (Figure 4A). It is worth noting that the observed alterations in
membrane shape are specific to M1. We have verified that extensive binding of another protein with high affinity to
phosphatidylserine (i.e. Annexin V) does not cause significant membrane deformation (see Supplementary Figure
S5).
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Figure 4. M1 layer interacting with the membrane is stable even after lipid removal
(A,B) LSM confocal image of a typical GUV composed of DOPC:cholesterol:DOPS 50:20:30, after incubation with 5 μM
M1-Alexa488 (green channel, (A)). The lipid bilayer is visualized via the addition of 0.05 mol% Rhodamine-DOPE (red channel,
(B)). (C,D) LSM confocal image of a (different) typical GUV after treatment for 5 min with detergent (e.g. Triton X-100 1.7 mM). (C)
Represents the signal from M1-Alexa488. (D) Represents the signal from Rhodamine-DOPE. The excitation laser power used to
acquire the image shown in (D) was approximately seven-times higher than the power used to acquire the image shown in (B). All
GUVs contained 150 mM sucrose in their lumen and were suspended in a phosphate buffered protein solution (NaCl ∼25 mM, pH
7.4) with similar osmolarity (see ‘Materials and method’ section). Scale bars are 5 μM. Images were acquired at 23◦C.
We then proceeded to dissolve the GUVs, by adding 1.7 mM Triton X-100. Most of the lipids were effectively dis-
solved by the treatment, as demonstrated by the strong decrease in the fluorescence signal of the lipid analog (Figure
4D, for an exemplar GUV). Interestingly, we observed that the protein was not affected by the detergent treatment,
as it formed an apparently stable lipid-free three-dimensional structure (Figure 4C). We obtained similar results if
lipids were dissolved using amixture of different detergents (Triton X-100 1.7mM, n-Dodecylphosphocholine 1mM,
CHAPS 10 mM and n-Dodecyl-β-Maltoside 1 mM).
M1–M1 interactions are needed for membrane deformation
The previous results suggested that M1 forms a protein network around GUVs that remains stable even after lipid re-
moval. This observation hints at the presence of significant inter-protein interactions. To verify whether suchM1–M1
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 5. M1-induced membrane deformation requires M1 multimerization
(A) Confocal LSM image of a typical GUV composed of 40 mol% DOPS and 60 mol% DOPC, in the presence of 10 μM fluores-
cent M1-Alexa488, which was pre-incubated with 100 μM PHE for 30 min. GUVs contained 150 mM sucrose in their lumen and
were suspended in a phosphate buffered protein solution (NaCl ∼45 mM, pH 7.4) with similar osmolarity (see ‘Materials and meth-
ods’ section). (B) Confocal LSM image of a typical GUV with the same composition as in (A), at pH 5, in the presence of 10 μM
M1-Alexa488. These GUVs contained 150 mM sucrose, 10 mM sodium acetate buffer solution at pH 5 in their lumen. The external
solution consisted of 10 μM M1-Alexa488 in ∼15 mM sodium acetate buffer (pH 5) with ∼70 mM NaCl and ∼30 mM sucrose (i.e.
slightly hyperosmotic conditions, see ‘Materials and methods’ section). Scale bars are 5 μm. Images were acquired at 23◦C.
interactions have a specific role in altering membrane curvature, we investigated conditions that inhibited protein
multimerization, while not completely abolishingmembrane binding. First, we incubated GUVs containing 40mol%
DOPS in the presence of 10 μMM1-Alexa488 pre-treated with 100 μM PHE. PHE is a small molecule that disrupts
M1–M1 interactions, via direct interaction with the protein [37]. The abovementionedDOPS andM1 concentrations
were chosen so that a strong deformation of the GUV bilayer would have been expected (compare with e.g. Figure
1). Strikingly, most of the GUVs appeared spherical in the presence of PHE, as shown in Figure 5A. The same ob-
servation was made also under slightly different conditions (i.e. DOPS concentrations between 30 and 50 mol% and
M1-Alexa488 incubated with 75–150 μM PHE, see Table 1).
Second, we incubated GUVs containing DOPC and 40 mol% DOPS in the presence of 10 μMM1-Alexa488 at pH
5. Low pHwas already shown to interfere withM1multimerization [9,30,38–42]. Once again, we did not observe sig-
nificant alterations in the shape of the GUVs (see e.g. Figure 5B). The same effect was observed for GUVs containing
30 mol% DOPS (see Table 1 for a quantitative summary).
M1 exhibited reduced dynamics and high degree of multimerization in
deformed vesicles
The results described in the previous paragraphs strongly suggest thatM1multimerization plays a determinant role in
causing bilayer deformation. As an alternative approach to characterize protein–protein interactions, we performed
sFCS measurements on protein- bound GUVs. We have used in the past similar fluorescence fluctuation analysis
methods to characterize M1 multimerization upon interaction with lipid bilayers [9]. In this study, we used sFCS to
directly quantitate protein binding, dynamics andmultimerization in spherical or deformedGUVs. It is worth noting
that the sFCS approach (compared with e.g. point-FCS) is particularly suitable to investigate non-supported mem-
branes, such as GUVs or the cellular PM.We incubated GUVs containing 30 mol%DOPS with 10 μMM1-Alexa488,
in different conditions. First, we compared the properties of M1 bound to spherical or deformed GUV within a
sample prepared at pH 7.4 (these measurements are referred to as ‘Spherical’ and ‘Deformed’, respectively). As re-
ported in Table 1, such samples contain in average ∼50% deformed GUVs. Furthermore, we have performed sFCS
on M1-Alexa488 bound to spherical GUVs in samples that were treated with the M1 multimerization inhibitor PHE
[37] or that were prepared at pH 5 (these measurements are referred to as ‘PHE’ and ‘pH 5’, respectively). Both condi-
tions are supposed to be characterized by lowM1 multimerization and reduced membrane deformation, as reported
in the previous paragraph. Figure 6A shows, for the abovementioned experimental conditions, themeasuredmolecu-
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Figure 6. sFCS analysis of M1 brightness and dynamics in spherical and deformed GUVs
(A,B) GUVs composed of 30 mol% DOPS and 70 mol% DOPCwere incubated with 10 μMM1-Alexa488. The categories ‘Spherical’
and ‘Deformed’ refer to measurements in GUVs from samples at pH 7.4 (NaCl ∼45 mM), in the absence of PHE. In these conditions,
∼50% of the GUVs are clearly non-spherical (see Table 1). The category ‘PHE’ refers to spherical GUVs in samples prepared at pH
7.4 (NaCl ∼45 mM), using 100 μMPHE. In these conditions, ∼90% of the GUVs are clearly spherical (see Table 1). The category ‘pH
5’ refers to spherical GUVs in samples prepared at pH 5 (NaCl ∼70 mM), in the absence of PHE. In these conditions, ∼90% of the
GUVs are clearly spherical (see Table 1). Details of sample preparation are described in the ‘Materials and methods’ section. sFCS
measurements were performed on 16–34 GUVs from two independent sample preparations and the results were pooled together.
Each measurement provided M1-Alexa488 normalized brightness values (shown as box plot in (A)), diffusion times (shown as
box plot in (B)) and normalized fluorescence intensities (shown in Supplementary Figure S6). Upper outliers from the ‘Deformed’
category are not included in the plot. ‘***’ indicates statistical significant difference between categories, with a t test probability
outcome P<0.01. ‘**’ indicates statistically significant difference between categories, with a t test probability outcome P<0.05. In
the case of diffusion time measurements (B), the category ‘Deformed’ is significantly different from all the other categories, with a
t test probability outcome P<0.01, in all cases.
lar brightness, i.e. the fluorescence signal detected for each diffusing object per unit of time. Considering that, in a very
simple approximation, a fluorescent n-mer contains n-times more fluorescent labels than a monomer, the molecular
brightness scales linearly with the size of the fluorescence multimers (e.g. a dimer would have a molecular brightness
two times larger than the one of a monomer). In other words, the molecular brightness can be used here to esti-
mate the clustering degree of membrane-bound proteins [9,10]. A normalization procedure was carried out to take
into account day-to-day variations in protein labeling efficiency and in the experimental setup (see ‘sFCS’ section).
Nevertheless, a conversion from molecular brightness into a precise multimeric state is, in this case, not straightfor-
ward. First, M1 is probably present as an undefined mixture of different multimeric species (and sFCS will detect a
weighted average of the different multimeric species). Second, the low degree of protein labeling (∼0.1 label/protein
ratio) implies that the effective number of fluorescentmolecules inmultimers of different sizes will be very similar. For
example, fluorescent monomers and the vast majority of fluorescent dimers will both contain exactly one fluorescent
label. This effect can be accounted for, as described by Dunsing et al. [31]. Third, the brightness value of a monomeric
reference would be required (i.e. a monomeric molecule labeled with the same fluorescent probe and diffusing in a
system with the same geometrical properties as M1-Alexa488) [26]. In this context, using the same fluorescent label
diffusing in solution or bound to a different (monomeric) protein on the membrane would not be a precise reference
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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in general, due to the different geometry [43] and possible changes in quantum yield of the probe, respectively. Nev-
ertheless, some simplifications can be made in order to estimate the multimerization variations among the different
samples. In the simple approximation that M1 is present (i) as a single multimeric species and (ii) in dimeric state
at pH 5 [30], we could estimate that M1 forms approximatively decamers in spherical vesicles, 25-mers (and up to
100-mers) in deformed vesicles, and 15-mers in samples treated with PHE. These estimations take into account the
degree of protein labeling, as described in ‘sFCS’ section. In summary, our brightness measurements indicate that
M1 bound to deformed vesicles (at pH 7.4, in the absence of PHE) is characterized by a significantly higher degree
of multimerization, compared with the protein bound to spherical GUVs within the same samples. Also, both lower
pH and the presence of the multimerization inhibitor PHE resulted in significantly decreased M1 multimerization,
as expected.
Additionally, sFCS provided quantitative information about M1-Alexa488 average diffusion dynamics. More pre-
cisely, we report the typical time needed by the protein to diffuse through a membrane area intersected by the detec-
tion volume. Such diffusion time is inversely proportional to the Brownian diffusion coefficient. The results shown
in Figure 6B indicate, as expected, that M1 dynamics in deformed vesicles is slower than that observed in all other
cases. It is worth noting that protein diffusion is, in general, dependent on both the size of protein assemblies and
protein–membrane interaction.
In conclusion, these data indicate that M1-induced membrane deformation is clearly accompanied by a signifi-
cant increase in protein multimerization and reduced protein dynamics. On the other hand, we did not observe a
simple correlation between total amount of bound protein and the induction of membrane deformation, as the total
fluorescence signal measured in deformed or spherical GUVs was similar (see Supplementary Figure S6).
Discussion
The proteinM1 is believed to play a fundamental role in the assembly of IAV [6]. In order to release a new virion from
the PM of an infected cell, the lipid bilayer has to undergo a shape change. In particular, some viral or cellular com-
ponent(s) must induce a negative curvature on the inner leaflet of the PM, so that a virion can bud out from the cell.
Previous studies have suggested that different viral proteinsmight be responsible for the reshaping of the PM [11–17].
M1 has also been suggested to be capable of inducing curvature in the bilayer, but no unequivocal evidence has been
presented yet. While investigations in cellulo provide information in a biologically relevant context (e.g. [12,13]), the
concurrent presence of several cellular and viral proteins does not allow the isolation and characterization of specific
protein-protein or protein–lipid interactions. For this reason, we have applied here a bottom-up approach and mod-
eled the interaction between M1 and the PM in a controlled environment. In particular, we have characterized the
interaction between M1 and physical models of the PM (i.e. GUVs or LUVs) using several microscopy methods. A
similar approach has been recently used to investigate the interaction between the matrix protein from the Influenza
C virus and lipid membranes [22]. It was shown that this specific matrix protein forms elongated structures on GUVs
and can also cause the formation of lipid tubules (by inducing negative membrane curvature). In spite of significant
similarities in tertiary structure, the low sequence similarity between the two proteins and themorphologically differ-
entmembrane formations observed in cells infected by the two viruses [44,45] do not allow extending the conclusions
regarding the matrix protein of Influenza C directly to Influenza A M1.
In the current work we have investigated for the first time the interaction between IAV M1 and GUVs containing
different amounts of DOPS. The protein concentration (much larger than the reported Kd values [10,39]) was chosen
so to take into account that, in vivo, viral proteins might be recruited to small PM domains [46] and, therefore, reach
a high local concentration [47]. Previous investigations on solid-supported bilayers have demonstrated thatM1 binds
to lipid membranes containing negatively charged lipids and that M1–lipid binding is accompanied by extensive pro-
tein multimerization [9]. In agreement with these observations, we have observed that M1 binds effectively to GUVs
containing DOPS. Surprisingly, M1 binding induced a significant alteration in the shape of the vesicles, especially at
higher phosphatidylserine concentrations (e.g.>30mol%, see Figure 1). Specifically, the N-terminal domain ofM1 is
sufficient to inducemembrane shape changes, in linewith previous findings suggesting that this domain of the protein
is responsible for M1–lipid andM1–M1 interactions [7,10]. In contrast, the N-terminal domain of Influenza CM1 is
not sufficient to cause membrane curvature [22]. Observation via optical microscopy indicates that M1 binds homo-
geneously while altering the spherical shape of vesicles. In general, both regions with positive and negative curvature
can be observed. It is reasonable to assume that GUVs might become (temporarily) unstable, due to the significant
and extensive deformation and volume decrease, thus allowing the internal solution to leak out. Accordingly, we have
observed that M1might indeed penetrate into the lumen of several vesicles and thus bind to both membrane leaflets.
Nevertheless, reproducible membrane deformation patterns are observed also in the cases in which the protein seems
12 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
Bioscience Reports (2019) 39 BSR20191024
https://doi.org/10.1042/BSR20191024
to bind only to the outer leaflet (Supplementary Figure S1 or, in the case of spatially limited deformations, Figure 3
and Supplementary Figure S4). Alterations in bilayer curvature were also observed if M1 was incubated with LUVs
with diameter∼100 nm. Thanks to the high spatial resolution of cryo-TEM and cryo-ET, M1-lipid interaction could
be observed with remarkable detail. On a nanometer scale, binding of the protein to the vesicles appears not homoge-
neous.M1 seems capable to induce tubulation and, in fewer cases, vesiculation. The protein is found also concentrated
in membrane regions with negative Gaussian curvature (i.e. at the neck of tubes) (Figure 2). While comparing these
results with the possible membrane-bending properties of M1 in a physiological context, it must be kept in mind
that LUVs are more curved compared with GUVs or the PM. The specific protein–lipid arrangements which are
observed for LUVs (e.g. approximately 20 nm radius observed for tubular structures) might therefore also be influ-
enced by the initial membrane curvature. Furthermore, the protein–lipid ratio used in the present study for GUV
samples was at least ten-times lower than the one used for LUV samples, and this difference might play a role in the
formation of protein–lipid structures. Finally, buffer concentrations in GUV and LUV samples were slightly different.
Nevertheless, taken together, the experiments performed in GUVs and LUVs suggest that M1 is sufficient to induce
membrane deformation.While no other membrane component appears necessary for M1-induced membrane bend-
ing, the possibility that e.g. other viral proteins might modulate this effect (by, e.g. making negative curvature of the
leaflet interacting with M1 energetically favorable over positive curvature) is currently under investigation. Further-
more, it is worth mentioning that M1 was reported to form various multimeric arrangements (e.g. helical [41]) that,
in vivo, might result in a different remodeling of lipid membranes, compared with the one presented in the current
work. Lipid ordering in the bilayer does not appear to play a dominant role in M1-induced membrane bending, since
we observed no effect induced by alteringmembrane fluidity (by increasing cholesterol content [48] or in the presence
of saturated lipids).We further noticed thatM1-induced deformation does not require lowmembrane lateral tension,
as it occurs also in hypoosmotic conditions (Supplementary Figure S5C,D). Additionally, our observation that signif-
icant shape alteration is observed only in bilayers containing higher amounts of DOPS is likely not connected to an
effect of this lipid on the physical properties of the membrane. It was suggested in fact that phosphatidylserine does
not decrease the bending stiffness of a lipid bilayer [49,50]. In conclusion, the observed alterations in bilayer shape are
brought about specifically by the binding of M1 to the membrane. Similar results are observed if M1 binds to GUVs
via interactions with other lipids (i.e. in the absence of phosphatidylserine), such as PG, PIP2 or metal-ion-chelating
lipids binding the His-tag of M1 (data not shown).
A further aspect that was examined in these experiments regarded the lateral organization of the bilayer, prior
to protein binding. Previous investigations have shown that M1 multimerization and binding to lipid membranes
are modulated by the presence of lipid domains containing negatively-charged lipids [34]. In infected cells, M1 clus-
ters are observed in correspondence of phosphatidylserine-rich membrane regions [34]. In order to clarify whether
M1-induced membrane restructuring is also affected by the lateral organization of the lipid bilayer, we investigated
lipid mixtures displaying phase separation. In particular, GUVs contained ordered domains (enriched in cholesterol,
saturated lipids including, reasonably, negatively charged saturated lipids) in a disordered bilayer (enriched in unsat-
urated lipids). In the presence of M1, the ordered domains showed variations from the original spherical shape and,
especially in the case of smaller domains, inward budding (see e.g. Figure 3B,C). This observation demonstrates, on
one hand, that these ordered domains are indeed enriched in acidic lipids to whichM1 can effectively bind. Second, it
indicates that themembrane restructuring effect ofM1 appears significant even at relatively high values of membrane
bending rigidity (cfr., for example, approximately 65 kT for a DPPC:cholesterol 80:20 bilayer [51]). Third, it suggests
that the local membrane restructuring induced by M1 might be modulated by the lateral lipid organization in the
bilayer region in which M1 is concentrated. This phenomenon might be relevant in vivo, since M1 is supposed to be
confined in budozones, i.e. small domains of the PM of infected cells from which IAV budding takes place [52].
Finally, we aimed to clarify the molecular mechanism driving the deformation of the membrane induced by M1.
Several mechanisms for the induction of membrane curvature driven by (non transmembrane) proteins were de-
scribed, including: membrane insertion, protein crowding and scaffolding [53–56]. In order to distinguish among
these possibilities, we observed M1–GUV interaction in conditions in which M1 could bind to the membrane but
protein multimerization was hindered (i.e. low pH or in the presence of a multimerization inhibitor, see Figure 5).
These experiments revealed that protein binding to the bilayer per se did not induce significant alterations in mem-
brane shape. The reduced ability ofM1 to form largemultimers in these conditions was confirmed via sFCSmeasure-
ments (Figure 6). Accordingly, the amount of M1 bound to deformed vesicles was not significantly higher than that
of M1 bound to spherical vesicles (Supplementary Figure S6). Finally, we verified that binding of another protein to
DOPS in GUVs (in comparable amounts withM1) did not affect membrane shape (Supplementary Figure S5). Taken
together, these observations suggest that membrane insertion (assuming that protein insertion is indeed not altered
by low pH or PHE treatment) or protein crowding might not be the main factors driving M1-induced curvature. On
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
13
Bioscience Reports (2019) 39 BSR20191024
https://doi.org/10.1042/BSR20191024
the other hand, we observed that M1 forms a protein network which is characterized by slow dynamics ( Supplemen-
tary Figure S5 and Figure 6B) and seems to impose its irregular (corrugated) shape on the underlying bilayer. The
strength of M1–M1 interactions allows the protein shell to remain stable even after removal of the lipid membrane
using detergents (Figure 4). Additionally, we were able to quantitatively verify that M1 bound to deformed vesicles
forms in general larger multimers (up to approximately ten-fold), compared with the case of spherical vesicles (Figure
6). In this regard, the limitations of the sFCS approach in this context should bementioned: First, the reported bright-
ness/multimerization and diffusion values refer to an average of different multimeric species that might be present in
the sample. Second, the presence of an immobile protein fraction would not be detected by fluorescence fluctuations
techniques which, in general, report only of the properties of diffusingmolecules. Third,membrane geometry and the
detection area are not well-defined in the case of deformedmembranes with large curvature (compared with the typ-
ical size of the detection volume of ∼300 nm). In other words, a larger than expected bilayer surface (due to ruffling
within the detection volume) might be observed during our experiments. As a consequence, protein diffusion times
and total fluorescence intensity might be overestimated in deformed vesicles. On the other hand, protein brightness
and multimerization would be underestimated. Of interest, these limitations do not affect our main findings that: (i)
the amount of M1 bound to deformed vesicles is not significantly higher than that of M1 bound to spherical vesicles
and (ii) M1 bound to deformed vesicles is characterized by a higher degree of multimerization.
In conclusion, our data show that IAV M1 binds to vesicles containing negatively-charged lipids, forming a stable
protein layer. This M1–M1 network seems to be characterized by both regions of negative and positive curvature,
although it appears that its precise spatial structure might be modulated by the initial curvature of the bilayer and the
presence of lipid-protein lateral confinement. Our results support themodel according to which theM1 shell, in vivo,
might drive the IAV budding (likely in concert with other membrane and/or viral components that help determining
a specific curvature) and provides mechanical stability to the newly formed virion (see e.g. [57]).
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